Oxetan-3-ylhydrazine dihydrochloride is primarily used in organic synthesis and pharmaceutical research. It serves as a key intermediate in the development of various bioactive compounds, particularly in the synthesis of heterocyclic molecules. Its application is significant in medicinal chemistry for designing and optimizing drug candidates, especially those targeting neurological and oncological disorders. The compound’s structure enables its use in click chemistry reactions, facilitating the creation of complex molecular architectures. Additionally, it is employed in the preparation of hydrazone derivatives, which are explored for their potential therapeutic properties. Its role in synthesizing novel chemical entities makes it valuable in drug discovery and development pipelines.